Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

LLY Eli Lilly and Co

867,75

-45,01 (-4,93%)

08 Mar 2025 - Fermé

Retardé de 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Eli Lilly (NYSE:LLY)
Graphique Historique de l'Action
De Fév 2025 à Mar 2025

Plus de graphiques de la Bourse Eli Lilly

Eli Lilly (NYSE:LLY)
Graphique Historique de l'Action
De Mar 2024 à Mar 2025

Plus de graphiques de la Bourse Eli Lilly

Actualités Eli Lilly and Co

Form PRE 14A - Other preliminary proxy statements
Vendredi 7 Mars 2025 ( il y a 10 heures) • Edgar (US Regulatory)

Lilly's EBGLYSS® (lebrikizumab-lbkz) single monthly maintenance injection achieved completely clear skin at three years in half of patients with moderate-to-severe atopic dermatitis
Vendredi 7 Mars 2025 ( il y a 18 heures) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Mardi 4 Mars 2025 ( il y a 3 jours) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Lundi 3 Mars 2025 ( il y a 4 jours) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Lundi 3 Mars 2025 ( il y a 4 jours) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Lundi 3 Mars 2025 ( il y a 4 jours) • Edgar (US Regulatory)

Lilly to participate in Leerink Partners Global Healthcare Conference
Vendredi 28 Février 2025 ( il y a 1 semaine) • PR Newswire (US)

Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with relapsed or refractory chronic lymphocytic leukemia (CLL) previously treated with a BTK inhibitor
Vendredi 28 Février 2025 ( il y a 1 semaine) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Mercredi 26 Février 2025 ( il y a 1 semaine) • Edgar (US Regulatory)

Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding $50 billion
Mercredi 26 Février 2025 ( il y a 1 semaine) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Mardi 25 Février 2025 ( il y a 1 semaine) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mardi 25 Février 2025 ( il y a 1 semaine) • Edgar (US Regulatory)

Plus d'articles sur Eli Lilly and Co

Societe Generale Effekten

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales